Publication Ethics

Journal of Medicinal Materials is committed to complying with publishing ethics in accordance with the provisions of the Press Law and Copyright.
To ensure the review and publication process is straightforward and to promptly handle violations, Journal of Medicinal Materials has issued publication ethics, which outline the duties of all parties involved in publishing.
- Duties of Editors:
+ Publication decisions: Based on a double-blind peer review process, Journal of Medicinal Materials gives a decision. It ensures that a manuscript meets the scope of the Journal, and legal requirements as well as not regarding issues such as libel, copyright infringement, and plagiarism.
+ Confidentiality: Journal of Medicinal Materials protects manuscript information during the review and publication process. The users’ information entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.
+ Fair play: The editor should evaluate manuscripts based on their intellectual content.
+ Disclosure and conflicts of interest: The editor does not use information in the unpublished manuscript for own research without the author's consent. Journal of Medicinal Materials does not allow the editor to review manuscripts with their participation or conflicts with the author's interests due to competition, cooperation, or relationships within the unit, company, or organization. All members of the Editorial Board are required to disclose conflicts (if available) during the review and publication process.
- Duties of Reviewers: Journal of Medicinal Materials's reviewers are scientists inside and outside of Institute of Medicinal Materials who have multiple publications in the relevant field for evaluating the manuscript and can assess its quality.
+ Confidentiality: All information related to the manuscript, discussions, and exchanges between reviewers and authors are protected confidential. Reviewers are not allowed to share information with others without the consent of the Editorial Board.
+ Conflict of interest: The reviewer must ensure that they do not have any conflict with the author or sponsor related to the manuscript. During the review process, if they have any dispute or contradiction, an incident report should be completed and sent to the Editorial Board.
+ Contribution to Editorial Board: Reviewers are responsible for providing suggestions to the Editorial Board regarding decision-making and assisting the author in improving the manuscript.
+ Objectivity: Reviewers always make objective and impartial judgments. Their views must be clear, specific, and appropriate.
+ Acknowledgement of sources: The reviewer must suggest to the author adding relevant published studies that the authors have not cited; check for plagiarism or similarities in the manuscript to others published.
- Duties of Authors:
+ Reporting standards: All information and data in the manuscript should be presented accurately and objectively. References are followed by the Journal of Medicinal Materials rule, making it easy for the reader to use. Fraudulent statements or inaccurate information in the manuscript is unacceptable ethically.
+ Data access and retention: Authors may be asked to provide manuscript data to support the review process. The author may prepare these data, allowing Journal of Medicinal Materials access in a certain period.
+ Originality and plagiarism: The authors should ensure they write the manuscript content. If they have used the work or words of others, this has been appropriately cited according to Journal of Medicinal Materials regulations on references.
Plagiarism takes many forms. Plagiarism in all forms is unethical publishing behavior and unacceptable. The author takes responsibility for plagiarism and copyright infringement. If the author has violated the cases above, they can submit their manuscript to the Journal of Medicinal Materials for 01 year from the date of discovery of the violation. Besides, they will be handled according to the Press Law and other law provisions.
+ Multiple, redundant or concurrent publication: Authors should submit manuscripts that have never been published. Until the Journal of Medicinal Materials Editorial Board makes the final decision, the author cannot submit this manuscript to other journals.
+ Authorship of the paper: People who have made a significant contribution to the design, execution, or interpretation of the study should be listed as co-authors. All those who participated in certain important aspects of the research should be listed in the Acknowledgments section. Authors should ensure that all co-authors agree to the final manuscript before publication.
+ Hazards and human or animal subjects: If the article researches issues related to chemicals, processes or equipment that are potentially dangerous, the author should show this information clearly in the manuscript. If the manuscript has content related to animals or humans, the author should ensure that they followed the laws, regulations, and instructions of relevant organizations and approved by them. Authors should provide evidence about permission to test on humans from relevant organizations according to the law.
+ Disclosure and conflicts of interest: Authors should disclose any conflicts affecting the article evaluation results. The Acknowledgments section should announce all sources of financial support for the project. Potential conflicts of interest should be shared at the earliest possible stage.
+ Fundamental errors in published works: If the author discovers mistakes or inaccuracies in the published article, the author should notify Journal of Medicinal Materials to adjust or withdraw the article promptly. If the editor finds errors in the paper after publication, the author should provide information or coordinate with the editor to edit the article.